Dirk Thye

Dirk Thye

Chief Executive Officer and Chief Medical OfficeratIRulya Therapeutics· In proxies 2022–2025

Pay in FY2025-9% from the year before · IRulya Therapeutics stock +79.1% the same year

Dirk Thye was paid $2.5M in FY2025 (Dec), down 9%. IRulya Therapeutics stock rose 79.1% that year.

Pay$100 in the stock at the end of FY21 → $27
Pay is from the Summary Compensation Table of each IRulya Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. IRulya TherapeuticsPublic company · 4 yr
    • Chief Executive Officer and Chief Medical Officer2022 – Present · 4 yrStock in role -99%

Roles come from the proxy statements of each company.

Boards1

  • IRulya TherapeuticsDirector · 3 yr on the boardNot independent—Paid as an executive

Board seats come from each company's latest proxy statement.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?